Inventor

VENET MARC GASTON

FR40 patents

⚠️ This page may combine multiple inventors who share the name “VENET MARC GASTON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VENET MARC GASTON

JANSSEN PHARMACEUTICA NV

Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives

Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles

Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives

Farnesyl transferase inhibiting 2-quinolone derivatives

1,2-annelated quinoline derivatives

1,2-annelated quinoline derivatives

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Metabotropic glutamate receptor antagonists

Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors

Retinoic acid mimetic anlides

Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors

Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors

Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives

Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives

Mycobacterial inhibitors

Respiratory syncytial virus replication inhibitors

Retinoic acid mimetic anilides

1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors

Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

Retinoic acid mimetic anilides

Retinoic acid mimetic anilides

Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles

Process for preparing enantiomerically pure 6-{4-chlorophenyl) (1 H-1,2,4-triazol-1-YL) methyl}-1-methyl-1 H-benzotriazole

Process for preparing enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl]-1-methyl-1H-benzotrizole

Farnesyl transferase inhibiting benzoheterocyclic derivatives

N-[4-(heteroarylmethyl)phenyl]-heteroarylamines

6- triazolyl 3-(trifluoromethyl)phenyl!methyl!-2-quinolines and -quinolinethiones

Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles

Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles

IL-5 inhibiting 6-azauracil derivatives

IL-5 inhibiting 6-azauracil derivatives

JANSSEN CILAG S A

Farnesyltransferase inhibiting quinazolinones

N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines

VENET MARC GASTON

Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer

Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer

JANSSEN PHARMACAEUTIC N V

Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives

JANNSEN CILAG S A

Farnesyltransferase inhibiting quinazolinones

ANGIBAUD PATRICK RENE

Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives